ArticleJournal of cell science2026
Stress- and mitosis-dependent phosphorylation of NIFK on Ser247.
Article in Journal of cell science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
NIFK is a nucleolar protein involved in ribosome biogenesis that interacts with Ki-67 (also known as MKI67) and is recruited to the perichromosomal layer during mitosis. NIFK expression is elevated in multiple cancers, and its expression correlates with poor prognosis. Although NIFK is highly phosphorylated, the regulation and functional significance of NIFK phosphorylation is not fully understood. Here, we identify Ser247 as a stress- and mitosis-responsive phosphorylation site on NIFK. Stress induces Ser247 phosphorylation through p38 mitogen-activated protein kinases (p38 MAPKs) and MSK1 (also known as RPS6KA5). Independently of stress, Ser247 is phosphorylated during mitosis by Aurora B (AURKB). In vitro assays confirm that MSK1 and Aurora B directly phosphorylate Ser247. During mitosis, Ser247 phosphorylation acts as a priming event enabling extensive multisite phosphorylation of NIFK. Mutation of Ser247 (S247A) abolishes this phosphorylation cascade but does not impair recruitment of NIFK to mitotic chromosomes. Nonetheless, cells with a NIFK S247A mutation display a delay in mitotic entry. Whether S247A mutation affects the ribosome biogenesis function of NIFK is not clear. These findings reveal that Ser247 is a hub integrating stress and mitotic cues, and establish it as a priming site for mitotic hyperphosphorylation of NIFK.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.